Cargando…
Canagliflozin, characterized as a HDAC6 inhibitor, inhibits gastric cancer metastasis
Gastric cancer is a common gastrointestinal cancer. Survival outcome for patients with the recurrence or metastasis remains poor due to the lack of effective targeting drugs. The mechanisms of non-histone acetylation modifications are key epigenetic regulations that participate in various biological...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9705739/ https://www.ncbi.nlm.nih.gov/pubmed/36457493 http://dx.doi.org/10.3389/fonc.2022.1057455 |